China FeNo testing market is projected to register a substantial CAGR of 13.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
China FeNO Testing Market, By Type (Nitric Oxide Handheld Monitor, Nitric Oxide Standalone Monitor and Others), Indication (Eosinophilic Airway Inflammation, Atopic Asthma, Chronic Respiratory Symptoms, COPD with Mixed Inflammatory Phenotype, Eosinophilic Bronchitis, Pulmonary Arterial Hypertension, Corticosteroid Responsiveness, Cystic Fibrosis, Others), End User (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, Homecare Setting, Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales), Country (China) - Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the China FeNO Testing market are:

- Increasing asthma cases in the China
- Technological advancement in FeNo Testing
Market Players:

The key market players for China FeNO Testing market are listed below:

- Bedfont Scientific Ltd.
- Spirosure, Inc,
- Medisoft Group
- Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH)
- Sunvou
- RuiBreath
- Circassia
- ECO MEDICS AG